Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL5828491

C[S+](C)Cc1ccccc1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.43
FAAH O00519 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
ELANE P08246 1/20 0.38
PRTN3 P24158 1/20 0.38
PRSS3 P35030 1/20 0.38
KCNH2 Q12809 6/20 0.38
ACHE P22303 5/20 0.38
PTPN1 P18031 1/20 0.36
CES1 P23141 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL8976229 0.85 GPR3 (0.46) GPR3FAAHPRSS1PRSS2ELANE
Trifluoromethanesulfonic Acid SCHEMBL1741788 0.85 GPR3 (0.40) GPR3FAAHPRSS1PRSS2ELANE
Trifluoromethanesulfonic Acid SCHEMBL31221554 0.84 KCNH2 (0.42) GPR3KCNH2ACHEPTPN1CA1
Trifluoromethanesulfonic Acid SCHEMBL31221579 0.83 ACHE (0.43) ACHECA1CA2
Trifluoromethanesulfonic Acid SCHEMBL31221635 0.81 CA2 (0.41) ACHECA1CA2
Trifluoromethanesulfonic Acid SCHEMBL7864830 0.81 GPR3 (0.42) GPR3FAAHPRSS1PRSS2ELANE
Trifluoromethanesulfonic Acid SCHEMBL6229697 0.80 KCNH2 (0.43) KCNH2ACHECA1CA2CA5A
SCHEMBL31475270 0.80 LMNA (0.43) FAAHPRSS1PRSS2ELANEPRTN3
Trifluoromethanesulfonic Acid SCHEMBL31221559 0.79 BCHE (0.47) ACHECA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL31221626 0.79 CYP19A1 (0.42) ACHECA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119192042-A Direct cross-coupling method of benzyl sulfonium salt and thiosulfate 南京工业大学 2024-12-27 CN claimed
WO-2025075065-A1 THERMALLY CATIONICALLY POLYMERIZABLE COMPOSITION, USE OF SAME, CATIONIC POLYMERIZATION METHOD USING SAME, AND STABILIZER FOR THERMALLY CATIONICALLY POLYMERIZABLE COMPOSITIONS 三新化学工業株式会社 2025-04-10 WO disclosed
CN-119192042-A Direct cross-coupling method of benzyl sulfonium salt and thiosulfate 南京工业大学 2024-12-27 CN disclosed
US-6991888-B2 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds AZ ELECTRONIC MATERIALS USA CORP. (US) 2006-01-31 US disclosed
EP-1516229-A2 PHOTORESIST COMPOSITION FOR DEEP ULTRAVIOLET LITHOGRAPHY COMPRISING A MIXTURE OF PHOTOACTIVE COMPOUNDS AZ Electronic Materials USA Corp. (US) 2005-03-23 EP disclosed
US-20030235782-A1 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds MERCK PATENT GMBH (DE) 2003-12-25 US disclosed
US-20030235775-A1 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds CLARIANT INTERNATIONAL LTD (CH) 2003-12-25 US disclosed
WO-2003107093-A2 PHOTORESIST COMPOSITION FOR DEEP ULTRAVIOLET LITHOGRAPHY COMPRISING A MIXTURE OF PHOTOACTIVE COMPOUNDS CLARIANT INTERNATIONAL LTD (CH) 2003-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030235782-A1 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds SUN2, UROD, ERCC1 GPR3 1055/4885FAAH 756/4885PRSS1 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.